The FUTURE biobank consists of residual biomaterial (serum and plasma) from the FUTURE study. The “Follow-Up of Transient ischemic attack and stroke patients and Unelucidated Risk factor Evaluation” (FUTURE) study is a prospective cohort study of prognosis of stroke in young adults. This study comprised patients aged 18 through 50 years with a TIA, ischemic stroke or intracerebral hemorrhage (1980-2010). The associated clinical data consists of baseline and clinical characteristics, including demographic data, stroke subtype and vascular risk factors.
Want to know more about these subjects? Click on the buttons below for more news.
Related news items
Costs for internal researchers in case of request for samples26 May 2020
As of January 1, 2020, internal researchers who request samples from the Radboud Biobank will only be charged for the number of samples received.read more